Analyst Price Targets — HTGC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 18, 2026 1:09 pm | — | UBS | $15.50 | $15.47 | TheFly | Hercules Capital price target raised to $15.50 from $15 at UBS |
| February 13, 2026 10:36 am | — | Piper Sandler | $17.50 | $16.60 | TheFly | Hercules Capital downgraded to Neutral from Overweight at Piper Sandler |
| December 15, 2025 12:23 pm | Ethan Kaye | Capital One Financial | $19.75 | $18.83 | TheFly | Hercules Capital initiated with a Buy at Lucid Capital |
| November 4, 2025 10:06 am | — | Compass Point | $19.50 | $17.81 | TheFly | Hercules Capital upgraded to Buy from Neutral at Compass Point |
| October 14, 2025 1:20 pm | — | UBS | $18.50 | $17.06 | TheFly | Hercules Capital price target lowered to $18.50 from $19 at UBS |
| October 9, 2025 10:41 am | Crispin Love | Piper Sandler | $20.50 | $17.71 | TheFly | Hercules Capital price target lowered to $20.50 from $21 at Piper Sandler |
| July 18, 2024 7:03 am | Doug Harter | UBS | $20.00 | $21.32 | TheFly | Hercules Capital price target raised to $20 from $18.50 at UBS |
| July 10, 2024 7:12 am | Crispin Love | Piper Sandler | $22.00 | $20.50 | TheFly | Hercules Capital price target raised to $22 from $21.50 at Piper Sandler |
| May 3, 2024 9:19 am | Crispin Love | Piper Sandler | $21.50 | $19.21 | TheFly | Hercules Capital price target raised to $21.50 from $21 at Piper Sandler |
| April 10, 2024 6:57 am | Crispin Love | Piper Sandler | $21.00 | $18.41 | StreetInsider | Hercules Capital Inc (HTGC) PT Raised to $21 at Piper Sandler |
Latest News for HTGC
The latest trading day saw Hercules Capital (HTGC) settling at $16.37, representing a +1.61% change from its previous close.
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2026 financial results…
Hercules Capital (HTGC) reached $15.69 at the closing of the latest trading day, reflecting a -1.26% change compared to its last close.
EMERYVILLE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that it has entered into a strategic credit facility agreement with Hercules Capital, Inc.…
In the closing of the recent trading day, Hercules Capital (HTGC) stood at $15.58, denoting a +2.23% move from the preceding trading day.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.